{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-018677","form_type":"8-K","ticker":"ATOS","cik":"0001488039","company_name":"ATOSSA THERAPEUTICS, INC.","filed_at":"2023-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.019141+00:00","generated_at":"2026-06-13T15:30:03.567853+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Atossa Therapeutics authorizes $10M stock repurchase program through Dec 31, 2023","bullets":["Board approved repurchase of up to $10M of common stock through December 31, 2023.","Program is less than 10% of total cash as of March 31, 2023; cash runway exceeds three years.","Repurchases may occur in open market or private transactions; no obligation to buy any shares.","CEO states confidence in strategic priorities; CFO cites attractive valuation opportunity.","Program may be suspended, modified, or terminated at any time without prior notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-018677","json":"https://secwatch.observer/filing/0001437749-23-018677.json","markdown":"https://secwatch.observer/filing/0001437749-23-018677.md","text":"https://secwatch.observer/filing/0001437749-23-018677.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923018677/0001437749-23-018677-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923018677/atos20230627_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T15:30:03.567853+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}